Nihon Kohden (6849.T)

Executive Summary

Nihon Kohden, a Japanese leader in medical electronics, specializes in patient monitoring, defibrillators, EEG, and diagnostic cardiology. Founded in 1951, the company has a strong global presence and is known for its innovation in critical care and neurophysiology. Its product portfolio includes bedside monitors, central monitoring systems, and electroencephalographs, supported by robust R&D in AI and cloud-based solutions. Financially, Nihon Kohden has demonstrated steady revenue growth, driven by demand in aging markets and hospital digitalization. However, competition from Philips, GE Healthcare, and Mindray remains intense, and the company faces pricing pressure in emerging markets. Overall, Nihon Kohden is well-positioned to capitalize on secular trends in healthcare technology, with a focus on enhancing clinical workflow and patient outcomes.

Upcoming Catalysts (preview)

• Q3 2026Q3 FY2026 Earnings Release90% success
• Q3 2026FDA Clearance for Next-Generation Patient Monitor with AI Analytics60% success
• Q4 2026Partnership Announcement for Expansion in India or Southeast Asia50% success